← Back to Search
Discovery Of Potent, Selective, Orally Active, Nonpeptide Inhibitors Of Human Mast Cell Chymase.
M. N. Greco, M. J. Hawkins, E. T. Powell, H. Almond, Lawrence de Garavilla, J. Hall, L. Minor, Y. Wang, Thomas W Corcoran, E. Di Cera, A. M. Cantwell, S. Savvides, B. Damiano, B. Maryanoff
Published 2007 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.
This paper is referenced by
Phosphorylation of C-H bonds of aromatic compounds using metals and metal complexes
Yu H Budnikova (2015)
Chapter 5.1 Five-membered ring systems: thiophenes and Se/Te analogues
Tomasz Janosik (2009)
Comprehensive synthesis of photoreactive (3-trifluoromethyl)diazirinyl indole derivatives from 5- and 6- trifluoroacetylindoles for photoaffinity labeling.
Yuta Murai (2012)
Potency variation of small-molecule chymase inhibitors across species.
J. Kervinen (2010)
Synthesis of 1-amino-2-vinylcyclopropane-1-phosphinates. Conversion of a phosphonate to phosphinates
Hyung-Jung Pyun (2012)
Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases.
Jatinder Singh (2016)
UV-Photoelectron Spectroscopy of BN Indoles: Experimental and Computational Electronic Structure Analysis
A. Chrostowska (2014)
Review on modern advances of chemical methods for the introduction of a phosphonic acid group.
Charles S. Demmer (2011)
Detection of chymase activity using a specific peptide probe conjugated onto gold nanoparticles
Hui-Fang Chang (2018)
1.7 Stereochemical Lability in Drug Molecules: Cases Where Chirality May Not Be Critical for Drug Development
Bruce E Maryanoff (2012)
Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris.
Eliot T Smith (2014)
Mast cell peptidases: chameleons of innate immunity and host defense.
N. Trivedi (2010)
Synthesis of indole analogues of the natural schweinfurthins.
John G. Kodet (2013)
ACE in the hole
Tim Fulmer (2010)
Discovery of potent, selective chymase inhibitors via fragment linking strategies.
S. J. Taylor (2013)
Crystal structure of a complex of human chymase with its benzimidazole derived inhibitor
Yoshiyuki Matsumoto (2013)
Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design
M. Arooj (2013)
Synthesis of indolylalkylphosphonates and 3-(1 -diphenylphosphinoalkyl) indoles by reaction of 3-(1-arylsulfonylalkyl) indoles with phosphorus derivatives
M. Petrini (2008)
Three-component 3-(phosphoryl)methylindole synthesis from indoles, H-phosphine oxides and carbonyl compounds under metal-free conditions
Jiaoting Pan (2019)
Chapter 590 – Chymases
George H. Caughey (2013)
Cleaved SLPI, a novel biomarker of chymase activity
S. M. Belkowski (2008)
Expeditious synthesis of 2,3-dihydro-2-alkoxy-3-methylenebenzofurans from N-benzofuran-3-ylmethyl N,N,N-trialkylammonium bromides: a new approach to access the natural product, 2-hydroxy-3-methylene-6-methyl-2, 3-dihydrobenzofuran
Yuanxiang Wang (2009)
A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
M. Arooj (2013)
Structure-based virtual screening for novel chymase inhibitors by in silico fragment mapping.
Shin-ichiro Ozawa (2019)
Guinea Pig Chymase Is Leucine-specific
G. Caughey (2008)
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
S. Ahmad (2018)
Preparation, Reactivity, and Synthetic Utility of Simple Benzotriazole Derivatives
Romaric Gérardy (2015)
Dissecting the role of mutations in chymase inhibition: Free energy and decomposition analysis.
S. Verma (2017)
Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors
Weilong Zhong (2017)
Novel diphenyl esters of peptidyl α-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin
Ewa Pietrusewicz (2009)
Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.
M. Clarke (2011)
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Jay M. Matthews (2012)See more